SEC Form 3 · accession 0000899243-18-025599
GW PHARMACEUTICALS PLC · GWPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher J. Tovey
Officer — Chief Operating Officer
Period of report
Oct 1, 2018
Accepted (ET)
Oct 1, 2018 · 6:41 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001351288
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | holding | — | — | — | 2,503 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF2,F3 | $0.0013 | holding | — | — | — | Jun 24, 2019 | Jun 24, 2025 | Ordinary Shares | 3,930 | — | D |
| Stock OptionsF2,F3 | $0.0013 | holding | — | — | — | Jun 24, 2018 | Jun 24, 2025 | Ordinary Shares | 7 | — | D |
| Stock OptionsF2,F3 | $8.7364 | holding | — | — | — | Jun 24, 2018 | Jun 24, 2025 | Ordinary Shares | 27,924 | — | D |
| Stock OptionsF2,F3 | $0.0013 | holding | — | — | — | Feb 15, 2019 | Feb 15, 2026 | Ordinary Shares | 10,457 | — | D |
| Stock OptionsF2,F3 | $0.0013 | holding | — | — | — | Feb 15, 2020 | Feb 15, 2026 | Ordinary Shares | 10,457 | — | D |
| Stock OptionsF2,F3 | $0.0013 | holding | — | — | — | Feb 15, 2019 | Feb 15, 2026 | Ordinary Shares | 139,420 | — | D |
| Stock OptionsF2,F3 | $3.3461 | holding | — | — | — | Feb 15, 2019 | Feb 15, 2026 | Ordinary Shares | 73,508 | — | D |
| Stock OptionsF2,F3 | $0.0013 | holding | — | — | — | Jan 6, 2019 | Jan 6, 2027 | Ordinary Shares | 6,468 | — | D |
| Stock OptionsF2,F3 | $0.0013 | holding | — | — | — | Jan 6, 2020 | Jan 6, 2027 | Ordinary Shares | 6,468 | — | D |
| Stock OptionsF2,F3 | $0.0013 | holding | — | — | — | Jan 6, 2021 | Jan 6, 2027 | Ordinary Shares | 6,468 | — | D |
| Stock OptionsF2,F3 | $0.0013 | holding | — | — | — | Jan 6, 2020 | Jan 6, 2027 | Ordinary Shares | 86,244 | — | D |
| Stock OptionsF2,F4 | $9.8117 | holding | — | — | — | Jan 6, 2020 | Jan 6, 2027 | Ordinary Shares | 52,560 | — | D |
| Stock OptionsF2,F3 | $0.0013 | holding | — | — | — | Feb 26, 2019 | Feb 26, 2028 | Ordinary Shares | 8,952 | — | D |
| Stock OptionsF2,F3 | $0.0013 | holding | — | — | — | Feb 26, 2020 | Feb 26, 2028 | Ordinary Shares | 8,952 | — | D |
| Stock OptionsF2,F3 | $0.0013 | holding | — | — | — | Feb 26, 2021 | Feb 26, 2028 | Ordinary Shares | 8,952 | — | D |
| Stock OptionsF2,F3 | $0.0013 | holding | — | — | — | Feb 26, 2022 | Feb 26, 2028 | Ordinary Shares | 8,952 | — | D |
| Stock OptionsF2,F3 | $0.0013 | holding | — | — | — | Feb 26, 2021 | Feb 26, 2028 | Ordinary Shares | 119,340 | — | D |
| Stock OptionsF2,F4 | $9.6092 | holding | — | — | — | Feb 26, 2021 | Feb 26, 2028 | Ordinary Shares | 58,884 | — | D |
Explanation of responses
- F12,496 of these ordinary shares are represented by American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer.
- F2Granted pursuant to the Issuer's Long-Term Incentive Plan.
- F3Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.302 U.S. Dollars as of September 28, 2018.
- F4The reported options are options to purchase ADSs.